← Back to Search

Package Standardization for Smoking Prevention

N/A
Recruiting
Research Sponsored by RAND
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after shopping in the rand storelab
Awards & highlights

Study Summary

This trial aims to test if plain packaging of tobacco affects young adults' intention to smoke, based on their past experience.

Who is the study for?
This trial is for young adults aged between 21-29 who have smoked cigarettes in the past month. There are no specific exclusion criteria, so a wide range of smokers within this age group can participate.Check my eligibility
What is being tested?
The study is looking at how changing cigarette packaging to a standardized color affects the intentions of young adults to use tobacco. It's an experiment focusing on whether less appealing packaging can influence smoking habits.See study design
What are the potential side effects?
Since this trial involves no medical interventions or drugs but rather changes in product packaging, there are no direct side effects associated with participating in this research.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after shopping in the rand storelab
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after shopping in the rand storelab for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quit smoking motivation

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Partial standardizationExperimental Treatment1 Intervention
Cigarette packages appear with half of the package using a standardized color
Group II: Full standardizationExperimental Treatment1 Intervention
Cigarette packages appear with all of the packages fully standardized (by color and font)
Group III: Status Quo PackagesActive Control1 Intervention
Cigarette packages appear as they normally do - no standardization

Find a Location

Who is running the clinical trial?

RANDLead Sponsor
137 Previous Clinical Trials
509,349 Total Patients Enrolled

Media Library

Partial standardization Clinical Trial Eligibility Overview. Trial Name: NCT05973981 — N/A
Smoking/Cigarette Smoking Clinical Trial 2023: Partial standardization Highlights & Side Effects. Trial Name: NCT05973981 — N/A
Smoking/Cigarette Smoking Research Study Groups: Partial standardization, Full standardization, Status Quo Packages
Partial standardization 2023 Treatment Timeline for Medical Study. Trial Name: NCT05973981 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this scientific research open to those aged 75 and above?

"For this research, only individuals aged 21 to 29 are eligible for enrollment."

Answered by AI

Am I able to join the research program?

"This clinical trial is seeking approximately 900 participants aged between 21 and 29 who have a history of smoking/cigarette use. Candidates must meet these criteria to be eligible for inclusion."

Answered by AI

What is the cap on participants for this experiment?

"Affirmative. Clinicaltrials.gov records show that this clinical trial, initially posted on May 4th 2022, is recruiting 900 patients from one site. It has recently been updated on August 1st 2023."

Answered by AI

Are new participants able to join this clinical trial now?

"Indeed, the data listed on clinicaltrials.gov indicates that this medical trial is recruiting patients at present. It was originally posted in May 2022 and then revised most recently in August 2023. The project requires 900 participants to be enrolled from a single site."

Answered by AI
~460 spots leftby Apr 2026